Recurrent submandibular fistula after Sunitinib treatment in a patient with renal cell carcinoma: a case report

Sunitinib is commonly used in the treatment of patients with renal cell carcinoma and is associated with serious side-effects. We present the first report of a recurrent submandibular fistula in a patient treated with sunitinib. A 68-year-old man was referred to our clinic for a cutaneous fistula si...

Descripción completa

Detalles Bibliográficos
Autores principales: Golu, Mihai Vlad, Paşcanu, Ionela, Petrovan, Cecilia, Cosarca, Adina, Bereczki, Despina Temistocle, Ormenisan, Alina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419685/
https://www.ncbi.nlm.nih.gov/pubmed/37577019
http://dx.doi.org/10.15386/mpr-2502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419685/
https://www.ncbi.nlm.nih.gov/pubmed/37577019
http://dx.doi.org/10.15386/mpr-2502

Ejemplares similares